You just read:

Alkermes Receives $50 Million Payment From Biogen Following Review of Preliminary Gastrointestinal Tolerability Data From the Ongoing BIIB098 Clinical Development Program

News provided by

Alkermes plc

06 Jun, 2018, 12:00 BST